This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Tuesday's ETF Winners & Losers

Exchange-traded funds tracking homebuilders and REITs were falling hard Tuesday, as traders continued to fret about the health of credit markets.

Among REIT-related ETFs, the iShares FTSE NAREIT Mortgage REITs (REM) was dropping $2.13, or 7.1%, to $27.73. The Ultra Real Estate ProShares (URE) gave back $2.38, or 5.6%, to $39.97. The iShares FTSE NAREIT Residential (REZ) was tumbling $1.31, or 2.9%, to $44.24.

Homebuilders were feeling the crunch as well. Beazer Homes (BZH) gave back 9% after Fitch Ratings downgraded its debt again. Meanwhile, Centex (CTX), Hovnanian (HOV) and Meritage Homes (MTH) were losing 3% or more.

The iShares Dow Jones U.S. Home Construction (ITB) was shedding 76 cents, or 3%, to $25.01. The SPDR S&P Homebuilders (XHB) was lower by 63 cents, or 2.4%, to $25.27.

Retail-related ETFs were also suffering following disappointing news out of the world's largest retailer, Wal-Mart (WMT), and Home Depot (HD).

Excluding items, Wal-Mart said it had earnings of 76 cents a share, matching the Thomson Financial estimate, but the company guided lower for the third quarter and full year. Meanwhile, Home Depot beat estimates by a nickel, but the home improvement retailer said that housing markets should remain soft into 2008.

The Retail HOLDRs (RTH) was shedding $2.60, or 2.6%, to $97.15. The SPDR S&P Retail (XRT) was down 94 cents, or 2.4%, to $38.10. The PowerShares FTSE RAFI Consumer Services (PRFS) was losing $1.15, or 2.2%, to $51.90.

There were few winners during Tuesday's session outside of the biotechnology arena. Earlier, Biogen Idec (BIIB) said it had positive phase II clinical trial data for its congestive heart failure treatment drug, Adentri.

The First Trust Amex Biotechnology Index (FBT) ETF was adding 24 cents, or 1%, to $23.95. The Biotech HOLDRs (BBH) was higher by $1.55, or 1%, to $163.75.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs